InvestorsHub Logo
Followers 22
Posts 3527
Boards Moderated 0
Alias Born 10/15/2016

Re: meirluc post# 38432

Sunday, 06/06/2021 12:12:13 PM

Sunday, June 06, 2021 12:12:13 PM

Post# of 43784
I believe the man has a Ph.D and works in this field

I can only complain so much


Well that is not a 50% chance of success because we all know is that for success, the Multikine treated arm must have at least 10% fewer events than SOC (-10%) and Mr. Sun's range of -10% to +10% therefore gives us hardly any room for success.



My way, which I suspect was a lot more time and effort, this "window" is very real. The question is, where is the window.

To the best of my ability it is 9.0% to 11.25% over all survival "improvement" in test arm. With a probability of 40+ events of difference at the end. ( maybe 100+ )

The reason I am positive about this is that the wonder drug "placebo" does not tend to perform at all for cancer. If it did, it could be as high as 7%.

I'm pretty sure we're at least 9%

And I believe the standards have relaxed since the start of the trial.

That means, we are also in a significant battle with the auxiliary arm for which we have absolutely no data. This arm clearly is designed to test "is it multikine or cisplatin" that is really doing all the work here. - conceivably a direct injection of that juice can render cancer cells more susceptible to radiation.

I believe we make it because there has to be a huge positive signal, it is unavoidable. Even if it is merely 9%, that is still yuge. Then add secondary measures... (quality of life)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News